Literature DB >> 29302713

Psilocybin disrupts sensory and higher order cognitive processing but not pre-attentive cognitive processing-study on P300 and mismatch negativity in healthy volunteers.

Anna Bravermanová1,2, Michaela Viktorinová1,3, Filip Tylš1,3, Tomáš Novák1,3, Renáta Androvičová1,3, Jakub Korčák1,3, Jiří Horáček1,3, Marie Balíková2, Inga Griškova-Bulanova4, Dominika Danielová1,3, Přemysl Vlček1,3, Pavel Mohr1,3, Martin Brunovský1,3, Vlastimil Koudelka1, Tomáš Páleníček5,6.   

Abstract

RATIONALE: Disruption of auditory event-related evoked potentials (ERPs) P300 and mismatch negativity (MMN), electrophysiological markers of attentive and pre-attentive cognitive processing, is repeatedly described in psychosis and schizophrenia. Similar findings were observed in a glutamatergic model of psychosis, but the role of serotonergic 5-HT2A receptors in information processing is less clear.
OBJECTIVES: We studied ERPs in a serotonergic model of psychosis, induced by psilocybin, a psychedelic with 5-HT2A/C agonistic properties, in healthy volunteers.
METHODS: Twenty subjects (10M/10F) were given 0.26 mg/kg of psilocybin orally in a placebo-controlled, double-blind, cross-over design. ERPs (P300, MMN) were registered during the peak of intoxication. Correlations between measured electrophysiological variables and psilocin serum levels and neuropsychological effects were also analyzed.
RESULTS: Psilocybin induced robust psychedelic effects and psychotic-like symptoms, decreased P300 amplitude (p = 0.009) but did not affect the MMN. Psilocybin's disruptive effect on P300 correlated with the intensity of the psychedelic state, which was dependent on the psilocin serum levels. We also observed a decrease in N100 amplitude (p = 0.039) in the P300 paradigm and a negative correlation between P300 and MMN amplitude (p = 0.014).
CONCLUSIONS: Even though pre-attentive cognition (MMN) was not affected, processing at the early perceptual level (N100) and in higher-order cognition (P300) was significantly disrupted by psilocybin. Our results have implications for the role of 5-HT2A receptors in altered information processing in psychosis and schizophrenia.

Entities:  

Keywords:  ERP; Human; MMN; Model of psychosis; P300; Psilocybin

Mesh:

Substances:

Year:  2018        PMID: 29302713     DOI: 10.1007/s00213-017-4807-2

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  79 in total

1.  Glutamatergic modulation of auditory information processing in the human brain.

Authors:  Handan Gunduz-Bruce; Robert M G Reinhart; Brian J Roach; Ralitza Gueorguieva; Stephen Oliver; Deepak C D'Souza; Judith M Ford; John H Krystal; Daniel H Mathalon
Journal:  Biol Psychiatry       Date:  2011-10-29       Impact factor: 13.382

Review 2.  Mismatch negativity--a unique measure of sensory processing in audition.

Authors:  R Näätänen; K Alho
Journal:  Int J Neurosci       Date:  1995       Impact factor: 2.292

3.  Clinical high risk and first episode schizophrenia: auditory event-related potentials.

Authors:  Elisabetta C del Re; Kevin M Spencer; Naoya Oribe; Raquelle I Mesholam-Gately; Jill Goldstein; Martha E Shenton; Tracey Petryshen; Larry J Seidman; Robert W McCarley; Margaret A Niznikiewicz
Journal:  Psychiatry Res       Date:  2014-11-29       Impact factor: 3.222

4.  Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale.

Authors:  R J Strassman; C R Qualls; E H Uhlenhuth; R Kellner
Journal:  Arch Gen Psychiatry       Date:  1994-02

Review 5.  Serotonin research: contributions to understanding psychoses.

Authors:  Mark A Geyer; Franz X Vollenweider
Journal:  Trends Pharmacol Sci       Date:  2008-09       Impact factor: 14.819

6.  Effects of quetiapine on cognitive functions in schizophrenic patients: a preliminary single-trial ERP analysis.

Authors:  Y Zhang; M Lehmann; A Shobeiry; D Höfer; S Johannes; H M Emrich; D E Dietrich
Journal:  Pharmacopsychiatry       Date:  2009-07-07       Impact factor: 5.788

Review 7.  Computational models of schizophrenia and dopamine modulation in the prefrontal cortex.

Authors:  Edmund T Rolls; Marco Loh; Gustavo Deco; Georg Winterer
Journal:  Nat Rev Neurosci       Date:  2008-09       Impact factor: 34.870

Review 8.  Mismatch negativity (MMN) as an index of cognitive dysfunction.

Authors:  Risto Näätänen; Elyse S Sussman; Dean Salisbury; Valerie L Shafer
Journal:  Brain Topogr       Date:  2014-05-17       Impact factor: 3.020

9.  Broadband cortical desynchronization underlies the human psychedelic state.

Authors:  Suresh D Muthukumaraswamy; Robin L Carhart-Harris; Rosalyn J Moran; Matthew J Brookes; Tim M Williams; David Errtizoe; Ben Sessa; Andreas Papadopoulos; Mark Bolstridge; Krish D Singh; Amanda Feilding; Karl J Friston; David J Nutt
Journal:  J Neurosci       Date:  2013-09-18       Impact factor: 6.167

10.  Neural correlates of the LSD experience revealed by multimodal neuroimaging.

Authors:  Robin L Carhart-Harris; Suresh Muthukumaraswamy; Leor Roseman; Mendel Kaelen; Wouter Droog; Kevin Murphy; Enzo Tagliazucchi; Eduardo E Schenberg; Timothy Nest; Csaba Orban; Robert Leech; Luke T Williams; Tim M Williams; Mark Bolstridge; Ben Sessa; John McGonigle; Martin I Sereno; David Nichols; Peter J Hellyer; Peter Hobden; John Evans; Krish D Singh; Richard G Wise; H Valerie Curran; Amanda Feilding; David J Nutt
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-11       Impact factor: 12.779

View more
  7 in total

1.  Psilocybin-Mediated Attenuation of Gamma Band Auditory Steady-State Responses (ASSR) Is Driven by the Intensity of Cognitive and Emotional Domains of Psychedelic Experience.

Authors:  Vojtěch Viktorin; Inga Griškova-Bulanova; Aleksandras Voicikas; Dominika Dojčánová; Peter Zach; Anna Bravermanová; Veronika Andrashko; Filip Tylš; Jakub Korčák; Michaela Viktorinová; Vlastimil Koudelka; Kateřina Hájková; Martin Kuchař; Jiří Horáček; Martin Brunovský; Tomáš Páleníček
Journal:  J Pers Med       Date:  2022-06-19

2.  P300-mediated modulations in self-other processing under psychedelic psilocybin are related to connectedness and changed meaning: A window into the self-other overlap.

Authors:  Lukasz Smigielski; Michael Kometer; Milan Scheidegger; Cornelia Stress; Katrin H Preller; Thomas Koenig; Franz X Vollenweider
Journal:  Hum Brain Mapp       Date:  2020-08-21       Impact factor: 5.038

3.  The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant Action.

Authors:  Daniela Dudysová; Karolina Janků; Michal Šmotek; Elizaveta Saifutdinova; Jana Kopřivová; Jitka Bušková; Bryce Anthony Mander; Martin Brunovský; Peter Zach; Jakub Korčák; Veronika Andrashko; Michaela Viktorinová; Filip Tylš; Anna Bravermanová; Tom Froese; Tomáš Páleníček; Jiří Horáček
Journal:  Front Pharmacol       Date:  2020-12-03       Impact factor: 5.810

4.  Classic Psychedelic Drugs: Update on Biological Mechanisms.

Authors:  Franz X Vollenweider; John W Smallridge
Journal:  Pharmacopsychiatry       Date:  2022-01-25       Impact factor: 2.544

5.  A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic Review.

Authors:  Niloufar Pouyan; Zahra Halvaei Khankahdani; Farnaz Younesi Sisi; Yena Lee; Joshua D Rosenblat; Kayla M Teopiz; Leanna M W Lui; Mehala Subramaniapillai; Kangguang Lin; Flora Nasri; Nelson Rodrigues; Hartej Gill; Orly Lipsitz; Bing Cao; Roger Ho; David Castle; Roger S McIntyre
Journal:  CNS Drugs       Date:  2022-09-12       Impact factor: 6.497

Review 6.  Biomarkers and neuromodulation techniques in substance use disorders.

Authors:  Bettina Habelt; Mahnaz Arvaneh; Nadine Bernhardt; Ivan Minev
Journal:  Bioelectron Med       Date:  2020-02-17

Review 7.  Catalysts for change: the cellular neurobiology of psychedelics.

Authors:  Matthew I Banks; Zarmeen Zahid; Nathan T Jones; Ziyad W Sultan; Cody J Wenthur
Journal:  Mol Biol Cell       Date:  2021-06-01       Impact factor: 4.138

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.